Track topics on Twitter Track topics that are important to you
A single dose of zoledronate does not adequately preserve bone mineral density gains seen with long-term denosumab treatment, once the latter is discontinued.
Medscape Medical News
Original Article: Single Shot of Zoledronate Doesn't Preserve BMD After DenosumabNEXT ARTICLE
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...